良信股份(002706.SZ)獲得上海市高新技術成果轉化項目扶持資金470.40萬元
格隆匯12月13日丨良信股份(002706.SZ)公佈,根據上海市人民政府《上海市促進高新技術成果轉化的若干規定》(滬府發〔2004〕52號)、上海市人民政府《關於實施上海中長期科學和技術發展規劃綱要(2006-2020年)若干配套政策的通知》(滬府發[2006]12號)、《高新技術成果轉化專項資金扶持辦法》(滬財企[2006]66號)等文件精神,公司符合相關規定,於近日收到上海市財政局撥付的2020年度高新技術成果轉化項目扶持資金470.40萬元。該次政府補助為企業高新技術成果轉化專項資金扶持,具有偶發性,是否持續存在不確定性。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.